eEF2K: an atypical kinase target for cancer.
Nat Rev Drug Discov. 2021 Aug;20(8):577. doi: 10.1038/d41573-021-00124-5.
Nat Rev Drug Discov. 2021.
PMID: 34257429
No abstract available.